Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP628368.RA_8U6SPfE0w-ucSI4y8tOPHXGNhpQ2ws_T-dqdTxQbb4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP628368.RA_8U6SPfE0w-ucSI4y8tOPHXGNhpQ2ws_T-dqdTxQbb4130_assertion type Assertion NP628368.RA_8U6SPfE0w-ucSI4y8tOPHXGNhpQ2ws_T-dqdTxQbb4130_head.
- NP628368.RA_8U6SPfE0w-ucSI4y8tOPHXGNhpQ2ws_T-dqdTxQbb4130_assertion description "[In conclusion, aberrant methylation of the CHFR gene may be useful as a molecular marker for selection of therapy for patients with cervical adenocarcinoma with a poor prognosis, and may also suggest a new therapeutic strategy of targeting CHFR in cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628368.RA_8U6SPfE0w-ucSI4y8tOPHXGNhpQ2ws_T-dqdTxQbb4130_provenance.
- NP628368.RA_8U6SPfE0w-ucSI4y8tOPHXGNhpQ2ws_T-dqdTxQbb4130_assertion evidence source_evidence_literature NP628368.RA_8U6SPfE0w-ucSI4y8tOPHXGNhpQ2ws_T-dqdTxQbb4130_provenance.
- NP628368.RA_8U6SPfE0w-ucSI4y8tOPHXGNhpQ2ws_T-dqdTxQbb4130_assertion SIO_000772 17786301 NP628368.RA_8U6SPfE0w-ucSI4y8tOPHXGNhpQ2ws_T-dqdTxQbb4130_provenance.
- NP628368.RA_8U6SPfE0w-ucSI4y8tOPHXGNhpQ2ws_T-dqdTxQbb4130_assertion wasDerivedFrom befree-2016 NP628368.RA_8U6SPfE0w-ucSI4y8tOPHXGNhpQ2ws_T-dqdTxQbb4130_provenance.
- NP628368.RA_8U6SPfE0w-ucSI4y8tOPHXGNhpQ2ws_T-dqdTxQbb4130_assertion wasGeneratedBy ECO_0000203 NP628368.RA_8U6SPfE0w-ucSI4y8tOPHXGNhpQ2ws_T-dqdTxQbb4130_provenance.